VITALI, CECILIA
VITALI, CECILIA
Dip. di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Effect of soy on metabolic syndrome and cardiovascular risk factors : a randomized controlled trial
2018 M. Ruscica, C. Pavanello, S. Gandini, M. Gomaraschi, C. Vitali, C. Macchi, B. Morlotti, G. Aiello, R. Bosisio, L. Calabresi, A. Arnoldi, C.R. Sirtori, P. Magni
EXAMINING THE DIVERSE CONTRIBUTIONS OF EL TO SYSTEMIC LIPID METABOLISM
2017 C. Vitali
Lipoprotein X causes renal disease in LCAT deficiency
2016 A. Ossoli, E.B. Neufeld, S.G. Thacker, B. Vaisman, M. Pryor, L.A. Freeman, C.A. Brantner, I. Baranova, N.O. Francone, S.J. Demosky, C. Vitali, M. Locatelli, M. Abbate, C. Zoja, G. Franceschini, L. Calabresi, A.T. Remaley
Role of LCAT in atherosclerosis
2016 A. Ossoli, S. Simonelli, C. Vitali, G. Franceschini, L. Calabresi
Soya-enriched mixed diet significantly improves cardiovascular and metabolic risk factors : A randomized controlled trial
2016 M. Ruscica, C. Pavanello, B. Morlotti, M. Gomaraschi, C. Vitali, R. Bosisio, C.R. Sirtori, A. Arnoldi, P. Magni
The relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype with preclinical atherosclerosis
2015 C. Pavanello, C. Vitali, C. Tarlarini, S. Penco, L. Calabresi
A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-IGuastalla)
2015 L. Pisciotta, C. Vitali, E. Favari, P. Fossa, M.P. Adorni, D. Leone, N. Artom, R. Fresa, L. Calabresi, S. Calandra, S. Bertolini
Evaluation of the health benefits of soy protein consumption in patients carrying the metabolic syndrome
2015 M. Ruscica, B. Morlotti, C. Pavanello, M. Gomaraschi, C. Macchi, C. Vitali, R. Bosisio, C. Sirtori, L. Calabresi, A. Arnoldi, P. Magni
Valutazione dei benefici salutistici dell'assunzione dI proteine della soia in pazienti con moderata sindrome metabolica
2015 B. Morlotti, M. Ruscica, C. Pavanello, M. Gomaraschi, C. Macchi, R. Bosisio, C. Vitali, C. Sirtori, L. Calabresi, A. Arnoldi, P. Magni
Lipoprotein (a) : concentration, isoforms, polymorphisms and association with preclinical atherosclerosis
2015 C. Pavanello, C. Vitali, C. Tarlarini, S. Penco, L. Calabresi, G. Mombelli, C.R. Sirtori
HDL and cholesterol handling in the brain
2014 C. Vitali, C.L. Wellington, L. Calabresi
Off-target effects of thrombolytic drugs : apolipoprotein A-I proteolysis by alteplase and tenecteplase
2013 M. Gomaraschi, A. Ossoli, C. Vitali, S. Pozzi, L. Vitali Serdoz, C. Pitzorno, G. Sinagra, G. Franceschini, L. Calabresi
HDL and endothelial protection : examining evidence from HDL inherited disorders
2013 M. Gomaraschi, A. Ossoli, C. Vitali, L. Calabresi
Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency
2013 S. Simonelli, C. Tinti, L. Salvini, L. Tinti, A. Ossoli, C. Vitali, V. Sousa, G. Orsini, M.L. Nolli, G. Franceschini, L. Calabresi